Adjuvant chemotherapy for primary breast cancer Journal Article
| Authors: | Fornier, M.; Hudis, C. |
| Article Title: | Adjuvant chemotherapy for primary breast cancer |
| Abstract: | For patients with hormone-unresponsive or higher-risk operable early-stage breast cancer, adjuvant chemotherapy significantly reduces the risks of relapse and death. The prognosis for such patients, especially those presenting with extensive axillary lymph node involvement, remains poor. New chemotherapy agents and novel administration schedules have recently been shown to improve clinical outcome. This overview provides a summary of the state of the art and the most recent developments regarding adjuvant chemotherapy for primary breast carcinoma. Copyright © 2005 by Current Science Inc. |
| Keywords: | cancer survival; treatment outcome; survival rate; myeloproliferative disorder; clinical trial; neutropenia; review; cancer recurrence; doxorubicin; fluorouracil; cancer risk; risk benefit analysis; antineoplastic agents; paclitaxel; chemotherapy, adjuvant; methotrexate; cancer staging; recurrence risk; lymph node metastasis; antineoplastic agent; breast cancer; tumor volume; neuropathy; myalgia; odds ratio; recurrence; cyclophosphamide; breast neoplasms; cancer mortality; risk; docetaxel; arthralgia; axillary lymph node; statistical analysis; statistical significance; adjuvant chemotherapy; drug response; surgical risk; medical oncology; epirubicin; high risk population; recombinant granulocyte colony stimulating factor; risk reduction; clinical trials |
| Journal Title: | Current Oncology Reports |
| Volume: | 7 |
| Issue: | 1 |
| ISSN: | 1523-3790 |
| Publisher: | Springer |
| Date Published: | 2005-01-01 |
| Start Page: | 18 |
| End Page: | 22 |
| Language: | English |
| PUBMED: | 15610682 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Cited By (since 1996): 1" - "Export Date: 24 October 2012" - "CODEN: CORUA" - "Source: Scopus" |
Citation Impact
Related MSK Work